
SOFA-2, validated in more than 3 million intensive care unit (ICU) patients, incorporates contemporary organ support treatments, showing strong predictive validity for ICU mortality in diverse international settings. Coauthor Mervyn Singer, MD, joins JAMA Associate Editor Christopher W. Seymour, MD, MSc, to discuss. Related Content: Rationale and Methodological Approach Underlying the Development of the Sequential Organ Failure Assessment (SOFA)–2 Score Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score A Revision to Organ Failure Assessment in Critically Ill Patients
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Private Equity's Growing Presence in Health Care: Promise or Peril?

A New Era in Dementia: Advances in Diagnostic Blood Tests, Novel Drugs, and the Power of Lifestyle Changes

AI Scribes Are Here, but Is Health Care Ready?

Rethinking the Autism "Epidemic": What's Driving the Rise in Diagnosis
Free AI-powered recaps of Healthy Dialogue and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.